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Despite many efforts of scientists and epidemiologists, the aetiology of endemic nephropathy (EN) is still 
unknown. This disease occurs in the rural population of geographically limited areas of Bulgaria, Bosnia 
and Herzegovina, Croatia, Romania, and Serbia, and a number of theories have been proposed about its 
aetiology. The mycotoxin theory has prevailed until now, based on the studies of nephrotoxic mycotoxin 
ochratoxin A (OTA) that revealed higher frequency of OTA-positive food and blood samples in endemic 
than in non-endemic areas.
However, a new aristolochic acid (AA) theory of EN origin has been proposed recently, due to the histological 
similarities in kidney lesions between patients suffering from EN and patients suffering from Chinese herbs 
nephropathy caused by AA. Until now it has not been unequivocally proved that the inhabitants of EN 
areas are exposed to higher concentration of AA than in other regions and the exposure pathways are 
rather uncertain.
This paper presents most important studies supporting both theories, indicating also the inconsistencies 
of each.
KEY WORDS: Chinese herbs nephropathy, DNA adducts, kidney tumours, mycotoxins, ochratoxin A, 
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Endemic nephropathy (EN) is a bilateral chronic 
kidney disease that occurs in the rural population of 
some areas of Bulgaria, Bosnia and Herzegovina, 
Croatia, Romania, and Serbia. This fatal disease is 
characterised by focused and limited geographical 
distribution, occurrence in farming households, and 
high mortality from uraemia. It is interesting that 
since the disease was discovered, the endemic areas 
are stable; there are no new endemic areas, and 
none of them has become non-endemic. There are 
no cases of EN in towns, although they are close to 
endemic villages. The first outbreak of the disease in 
the endemic areas of all affected countries occurred 
simultaneously in the early 1950s, although there are 
indications that sporadic cases were seen earlier. Ten 
years later, a high incidence of otherwise rare urothelial 
tumours was recorded, first in the endemic area of 
Bulgaria, and then of other countries. Although a 
number of more or less plausible hypotheses have 
been proposed, the origin of EN is still unknown.
The mycotoxin theory of the development of 
EN was postulated in the early 1970s, because of 
similar kidney lesions in pigs exposed to mycotoxin 
ochratoxin A (OTA) and humans suffering from EN. 
A number of field studies were performed, mostly in 
Bulgaria and Croatia, whose aim was to confirm or 
reject this theory.
In 1992 a number of cases of interstitial nephritis 
were recorded in young women in Belgium, and 
later in other European countries that were followed 
60
by end-stage renal disease (1). All patients followed 
the same slimming regimen with Chinese herbs that 
accidentally contained Aristolochia fangchi, a herb 
with a known nephrotoxic compound, aristolochic 
acid (AA) which causes the so called AA nephropathy 
(AAN). Histopathological similarities between kidney 
lesions in EN and AAN have recently resuscitated the 
old theory of the involvement of AA in EN.
This paper reviews the main research findings 
supporting or opposing either the OTA or AA theory 
of EN origin.
EPIDEMIOLOGICAL FEATURES OF ENDEMIC 
NEPHROPATHY AND CHINESE HERBS 
NEPHROPATHY
From the early 1950s when EN was recognised 
as a nosologic entity, its appearance in Croatia 
changed significantly. In 1957-1960 the average age of 
patients at death was 45.1 years, while in 1991-2002 
it was 69.2 years (2, 3). Although this increased life 
expectancy, similar to that of the general population 
in the area, is probably owed to lower exposure to 
the toxic compound, there are still new cases of the 
disease, and it does not disappear (4). 
EN occurs exclusively in rural population, even 
though the endemic areas are located near towns. 
It still has not been proved that chronic interstitial 
nephropathies of unknown aetiology seen in North 
Africa (Egypt and Tunis) are OTA-caused EN (5-
7), because high concentrations of OTA may also 
be found in patients with severe kidney failure (8). 
Therefore, it seems that EN neither expands nor 
disappears from the endemic areas (9). This is 
opposite to AAN, which appeared as an epidemic 
in the urban population first in Belgium in 1991 and 
then in other European countries, and the USA (10, 
12). The other difference is that EN is the disease 
of familial or environmental clustering, while AAN is 
not. The sex ratio in EN is approximately 1:1, while 
AAN is dominant in women because women attended 
slimming clinics (10). 
It also seems that exposure duration is quite 
different between EN and AAN. EN does not occur 
in children, but the inhabitants that have left the 
endemic area after over a decade of residence there 
are also known to develop EN. Patients with AAN 
usually developed the disease after several years of 
treatment with Chinese herbs (10, 11). In some cases 
nephropathy was characterised by a rapid deterioration 
in renal function, with initial serum creatinine doubling 
within about three months.
The development of urinary tract malignancy is 
also much slower in EN than in AAN. In the Croatian 
endemic area, the appearance of carcinomas of the 
urinary system peaked ten years after the peak of 
endemic nephropathy (2). In another endemic area, 
the latency for malignancies ranged between 20 and 
27 years, while in AAN urothelial tumours occurred 
within two to six years (13, 14). 
EXPOSURE TO OCHRATOXIN A AND 
ARISTOLOCHIC ACID IN THE ENDEMIC 
AREAS
Due to the endemic character of EN and its 
exclusive occurrence in rural population, it is believed 
that the causative agent of EN should be a natural 
nephrotoxic and carcinogenic compound more 
frequently found in the endemic than in non-endemic 
areas. The long latency of EN in persons who had lived 
in the endemic areas for at least 10 years and moved, 
suggests that the causative agent is slow-acting and 
that exposure continued for many years. 
Mycotoxin OTA is a natural compound with 
nephrotoxic and carcinogenic properties, and was 
extensively investigated as the possible cause of EN. 
This product of moulds from the genera Aspergillus 
and Penicillium was found in the food and feed in the 
endemic areas (15). In humans, OTA was first detected 
in the blood of residents of the Croatian endemic area 
(16). A ten-year follow-up of OTA blood concentrations 
showed that these residents were more frequently 
exposed to OTA than controls (17). This study was 
performed on samples collected in winter, but later 
studies showed that OTA exposure is the highest in 
the summer, which means that this ten-year follow up 
did not measure the peak exposure (18). In Bulgaria, 
576 blood samples were collected in the endemic 
and non-endemic areas in 1984, 1986, 1989, and 
1990. OTA was detected in all groups, but was more 
frequent in patients with EN and urinary tract tumours 
than in healthy subjects in the endemic and control 
areas (19). According to studies referred to here, 
residents of the endemic areas are more frequently 
exposed to OTA than other populations, but because 
of the high variability in OTA concentrations, mean 
blood OTA in patients with EN was not significantly 
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higher than in controls. OTA has demonstrated its 
nephrotoxic properties in all laboratory animals, and 
there is no reason that it should not have the same 
effects in humans. OTA was found in food and feed all 
over the world (20), and low OTA concentrations were 
found in residents of countries where EN has not been 
identified so far (21). However, this finding does not 
discard mycotoxins as possible causes of EN, because 
there are other mycotoxins (such as citrinin, penicillic 
acid, and fumonisins) with nephrotoxic properties that 
may have a synergistic effect (22-26). 
According to the AA theory, residents of the 
endemic areas suffering from EN are exposed to 
aristolochic acid from the seeds of Aristolochia 
clematitis (birthwort) contaminating the wheat. 
However, this exposure seems rather uncertain. The 
only paper dealing with this problem analysed a 
questionnaire about the presence of birthwort in the 
fields. Patients with verified EN remembered more 
frequently than healthy individuals that their fields were 
severely infested with birthwort (27). Both controls 
and EN patients declared that birthwort disappeared 
from their fields with more consistent use of herbicides 
and drainage that decreased humidity needed by 
the plant to grow. The authors did not mention that 
possible wheat contamination with birthwort 20 to 
30 years ago does not entail higher exposure to AA, 
because at that time the usual practice was that 
farmers brought sacks of wheat to the mill where they 
immediately exchanged them for sacks of flour from 
wheat produced by other farmers. In other words, it 
is hard to establish real exposure to AA. Furthermore, 
birthwort is ubiquitous in Croatia, and there is no 
explanation why it should cause severe lesions only 
in the endemic area. Other authors also raised similar 
doubts. Thus, Long and Voice (28) say that in an EN 
area wheat is typically harvested in mid-summer when 
birthwort seeds are immature and contained within 
a large bulb that can easily be separated from the 
wheat grain. They also claim that combine harvesters 
have been used in some villages for many years and 
that these would easily screen off immature bulbs. 
For long many villages have had modern mills with 
sophisticated separation technologies. There is no 
evidence that bread is contaminated, or that AA 
exposure is consistent with the occurrence of EN 
(29). It should be stressed that so far no food analysis 
has demonstrated the presence of AA in food of the 
residents of the endemic areas.
CLINICAL PICTURE OF EN AND AAN
Since the early description of EN given by Radoni} 
et al. (30), the clinical picture of this disease has not 
changed. EN is still a slow-progressing nephropathy 
of tubular type with the insidious onset. The initial 
appearance of interstitial fibrosis without affecting 
the glomerules and clinical presentation of mild 
hypertension is rather similar between EN and AAN. 
EN appears after non-specific signs such as fatigue, 
headache, loss of body weight, and pale skin. The 
effect on the tubules is characterized by a decrease 
in tubular transport that manifests itself in a very mild 
intermittent proteinuria and gradual rise of blood 
nitrogen (31). Mild anaemia either of aplastic or 
normochromic type is an early sign of EN, but blood 
pressure increases significantly only with greater 
impairment of the kidney function.
The main dermatological features of EN are yellow 
discoloration and dark stained palm lines that are not 
seen in AAN. In AAN anaemia is severe from the very 
beginning, and renal impairment may be slowed by 
steroid treatment (32). 
It takes decades for EN to progress from the non-
symptomatic phase to the end-stage renal disease, 
while in AAN this progression is much faster (a few 
months or years) (14, 31). The other difference in 
clinical picture is that ureterohydronephrosis has 
not been reported in EN except in cases of urothelial 
tumors, while it is frequent in AAN (14). The single 
pathological difference between the two diseases lies 
in the more extensive and constant involvement of the 
columns of Bertin in AAN than in EN (1).
OTA-DNA, AA-DNA ADDUCTS AND p53 
MUTATIONS IN EN AND AAN
It is well known that OTA and AA are carcinogenic 
in laboratory animals. Chemical carcinogens or their 
reactive metabolites bind covalently to the DNA 
molecule, forming thus DNA adducts. However, the 
presence of DNA adducts does not necessarily prove 
the involvement of a compound or its metabolite in 
the aetiology of cancer, but it does evidence exposure. 
OTA-DNA and AA-DNA adducts were found in the liver 
and kidney of experimental animals after respective 
OTA and AA treatment using the 32P-postlabelling 
method (33-35). Some authors have raised doubts 
about the origin of OTA-DNA adducts, suggesting 
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that OTA and its metabolites can not form covalent 
bonds with DNA, and that adducts seen in the tissues 
of OTA-treated animals are the products of OTA-
mediated cytotoxicity (36, 37).
In several studies, these adducts were detected 
either simultaneously or separately in human kidney or 
in tumour tissues of the urinary tract. In a preliminary 
study of OTA-DNA and AA-DNA adducts in the kidney 
tissue of three Croatian patients with EN, both types 
of DNA adducts were found simultaneously in two 
samples, while no adducts were found in one (38). 
OTA-DNA adducts were also found in eight tumour 
tissues of the kidney and urinary bladder of Bulgarian 
subjects that lived in a high-risk area for Balkan 
endemic nephropathy (39). In contrast, OTA-DNA 
adducts were not found in the tumour kidney tissues 
of French patients with AAN, analysed as controls. 
Instead, these and the tissues of surgically removed 
kidney, urothelial or tumor tissues of patients with AAN 
in Belgium contained only AA-DNA adducts (40). In 
a recently published paper OTA- and citrinin-DNA 
adducts were detected in the tumour kidney tissues 
of patients with EN from Croatia, Bulgaria, and Serbia, 
but AA-DNA adducts were not (41).
In contrast, there are authors reporting the 
presence of AA-DNA adducts in four renal cortex 
samples in patients with EN and in three upper urinary 
tract tumour samples in patients from the endemic 
area of Croatia (42). These samples were not checked 
for the presence of OTA-DNA adducts.
Carcinogenesis is believed to be genetically 
determined and a consequence of the disrupted 
function of tumour suppressor genes or of the 
activation of oncogenes. The most studied mutations 
are changes in the p53 suppressor gene. 
An analysis of p53 mutations revealed a statistically 
significant difference between mutation spectra in 
both the kidney and liver of AA-treated and control 
rats (34). In the liver and kidneys of AA-treated rats 
the predominant mutation was A:T®T:A transversion, 
whereas the main type of mutation in controls was 
G:C®A:T transition. Mutation A:T®T:A was found 
also in urothelial tumor cells of one patient with AAN 
(43). In 11 samples of transitional cell carcinomas in 
residents of endemic villages, 19 base substitutions 
were identified (42). All but one patient had at least 
one A:T®T:A mutation, and this mutation accounted 
for 78% of all base substitutions detected. This high a 
percentage of p53 mutations was not found in a study 
of 90 blood samples of Bulgarian patients with EN; 
they were found in 10 % of samples (44). 
CONCLUSIONS
EN is a disease that occurs endemically in rural 
population, which indicates that a natural toxin should 
be involved in the aetiology of this disease. OTA and 
AA have nephrotoxic and carcinogen properties, 
and exposure to either of them may cause severe 
kidney lesions and tumours of the urothelial system.
Until now, exposure to AA has been associated with 
the slimming regimen in young women in many 
highly developed countries, while EN has been the 
disease of the elderly rural population of both sexes. 
This suggests that the involvement of AA in the 
development of EN is not likely, which has also been 
concluded by Pfohl-Leszkowicz et al. (41).
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Sa`etak
MIKOTOKSINSKA I ARISTOLOHI^NA TEORIJA O UZROKU ENDEMSKE NEFROPATIJE
Unato~ mnogim nastojanjima znanstvenika i epidemiologa, etiologija endemske nefropatije (EN) jo{ 
nije razja{njena. Postavljeno je vi{e teorija o nastanku ove bolesti koja se javlja u ruralnom stanovni{tvu 
na geografski ograni~enim podru~jima Bugarske, Bosne i Hercegovine, Hrvatske, Rumunjske i Srbije. 
Donedavno se najvi{e napora ulagalo u istra`ivanje povezanosti nastanka EN s izlo`eno{}u mikotoksinu 
okratoksinu A. Prikupljeni rezultati upu}uju ve}im dijelom na opravdanost te pretpostavke. Zbog histolo{kih 
sli~nosti bolesnika s EN i pacijentica koje boluju od nefropatije uzrokovane kineskim travama za koju 
je ustanovljeno da ju uzrokuje aristolohi~na kiselina (AA) postavljena je teorija da je AA uzro~nik EN. 
Dosad nije potvr|eno da su stanovnici na lokalizacijama s endemskom nefropatijom izlo`eni povi{enim 
koncentracijama AA u usporedbi s podru~jima bez te bolesti. Osim toga su i putovi izlo`enosti AA koji bi 
se mogli povezati s pojavom EN nejasni i nedokazani. 
U ovom preglednom radu izneseni su rezultati najva`nijih istra`ivanja koja podupiru ili negiraju obje teorije, 
zajedno s nedostatcima svake od njih. 
KLJU^NE RIJE^I: DNA-adukti, mikotoksini, nefropatija kineskih trava, okratoksin A, p53, tumori 
bubrega
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